The Ministry of Health has recommended the registration of Lenacapavir, a long-acting HIV prevention medicine in a bid to ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...

The Ministry of Health has recommended the registration of Lenacapavir, a long-acting HIV prevention medicine.The move marks a major step toward expanding the country’s HIV prevention options.In a ...

I have immersed myself in the tech world for over five years, focusing my efforts on providing readers with in-depth reviews of gadgets. Exploring the ins and outs of the latest tech has been quite a ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Gilead Sciences Inc. (NASDAQ: GILD) on Monday shared topline results from the Phase 3 ARTISTRY-2 trial. The trial evaluated the treatment responses of adults with HIV ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment ...

– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from ...

– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory Submissions – FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today ...

The Federal High Court in Abuja on Thursday dismissed a no-case submission filed by former Minister of Power, Saleh Mamman. Justice James Omotosho, while delivering the ruling, held that the ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...